EnLIGHTenment of tumour vessel normalization and immunotherapy in glioblastoma

Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules

(2018) Bo He et al.   JOURNAL OF PATHOLOGY

Cell-penetrating peptide CGKRK mediates efficient and widespread targeting of bladder mucosa following focal injury

(2017) James I. Griffin et al.   Nanomedicine-Nanotechnology Biology and Medicine

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming

(2017) Lin Tian et al.   NATURE

New Directions in Anti-Angiogenic Therapy for Glioblastoma

(2017) Nancy Wang et al.   Neurotherapeutics

Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

(2017) Elizabeth Allen et al.   Science Translational Medicine

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?

(2017) Emily Jayne Colbeck et al.   Frontiers in Immunology

Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy

(2016) Anna Rita Cantelmo et al.   CANCER CELL

The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14)

(2016) Rana Herro et al.   PHARMACOLOGICAL RESEARCH

Intratumoral LIGHT Restores Pericyte Contractile Properties and Vessel Integrity

(2015) Anna Johansson-Percival et al.   Cell Reports

CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels

(2013) Quanyin Hu et al.   BIOMATERIALS

The Somatic Genomic Landscape of Glioblastoma

(2013) Cameron W. Brennan et al.   CELL

Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32

(2013) Lilach Agemy et al.   MOLECULAR THERAPY

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

(2011) L. Agemy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

LIGHT protein suppresses tumor growth by augmentation of immune response

(2009) Tomohiro Morishige et al.   IMMUNOLOGY LETTERS

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

(2008) Juliana Hamzah et al.   NATURE